Predictive Oncology (NASDAQ:POAI) Stock Price Passes Below Two Hundred Day Moving Average – What’s Next?

Shares of Predictive Oncology Inc. (NASDAQ:POAI) passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $1.12 and traded as low as $0.92. Predictive Oncology shares last traded at $0.94, with a volume of 30,631 shares.

Predictive Oncology Price Performance

The stock has a market capitalization of $8.38 million, a PE ratio of -0.31 and a beta of 1.20. The firm’s 50 day simple moving average is $1.03 and its 200 day simple moving average is $1.13.

Predictive Oncology (NASDAQ:POAI) last posted its quarterly earnings results on Wednesday, May 14th. The medical instruments supplier reported ($0.32) EPS for the quarter, missing the consensus estimate of ($0.09) by ($0.23). Predictive Oncology had a negative return on equity of 286.30% and a negative net margin of 1,012.32%. The business had revenue of $0.11 million for the quarter, compared to analysts’ expectations of $1.50 million. Analysts expect that Predictive Oncology Inc. will post -2.08 earnings per share for the current fiscal year.

About Predictive Oncology

Predictive Oncology Inc operates as a science-driven company on the oncology drug discovery. It provides various solutions for the oncology drug development. The company, through the integration of scientific rigor and machine learning, has developed the ability to advance molecules into medicine by introducing human diversity earlier into the discovery process with the pairing of artificial intelligence and the biobank of approximately 150K tumor samples.